BRAVO GROUP for WE WORK FOR HEALTH
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Biopharmaceutical issues including: social and economic, value of the biopharmaceutical sector, patient access and safety issues, drug importation, life science innovation, and job impact.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRIS BRAVACOS New | — |
| MATTHEW S CROCCO New | — |
| BROOKE READY New | — |
| IVANA WOLFE New | — |
Medical/Disease Research/Clinical Labs MED
Biopharmaceutical issues including: social and economic, value of the biopharmaceutical sector, patient access and safety issues, drug importation, life science innovation, and job impact.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRIS BRAVACOS New | — |
| MATTHEW S CROCCO New | — |
| BROOKE READY New | — |
| IVANA WOLFE New | — |
Medicare/Medicaid MMM
Biopharmaceutical issues including: social and economic, value of the biopharmaceutical sector, patient access and safety issues, drug importation, life science innovation, and job impact.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRIS BRAVACOS New | — |
| MATTHEW S CROCCO New | — |
| BROOKE READY New | — |
| IVANA WOLFE New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.